Clinicopathologic significance and therapeutic implication of de novo CD5+ diffuse large B-cell lymphoma.

CONCLUSION: CD5+ DLBCL patients have the distinctive clinical and biological features, they should be provided with clinic individualized treatment and important pathways with therapeutic implications should be underscored. PMID: 31072235 [PubMed - in process]
Source: Hematology - Category: Hematology Tags: Hematology Source Type: research